LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases

Cutis Verticis Gyrata in Association With Vemurafenib and Whole-Brain Radiotherapy

(2014) James J. Harding et al.   JOURNAL OF CLINICAL ONCOLOGY

Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study

(2013) Reinhard Dummer et al.   EUROPEAN JOURNAL OF CANCER

Severe Liver and Skin Toxicity After Radiation and Vemurafenib in Metastatic Melanoma

(2013) Christopher J. Anker et al.   JOURNAL OF CLINICAL ONCOLOGY

Vemurafenib and radiation therapy in melanoma brain metastases

(2013) Ashwatha Narayana et al.   JOURNAL OF NEURO-ONCOLOGY

Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib

(2013) B. Schulze et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Vemurafenib and Radiosensitization

(2013) Lise Boussemart et al.   JAMA Dermatology

Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF Pathway

(2012) Victor Huang et al.   ARCHIVES OF DERMATOLOGY

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

(2012) Georgina V Long et al.   LANCET ONCOLOGY

Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation

(2012) Nicole M. Rochet et al.   MAYO CLINIC PROCEEDINGS

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

(2012) Jeffrey A. Sosman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vemurafenib for Melanoma Metastases to the Brain

(2011) Nicole M. Rochet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032

(2011) Maria J. Sambade et al.   RADIOTHERAPY AND ONCOLOGY

Determinants of survival in patients with brain metastases from cutaneous melanoma

(2010) M Staudt et al.   BRITISH JOURNAL OF CANCER

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

(2010) Gideon Bollag et al.   NATURE

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER